Trial · NCT01737697
Participant flow90
How many started, completed or left each group, period by period.
1 to 20 of 90
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Acute Phase-Initial 48 Hours | STARTED | Acute Phase: Placebo | 158 | |
| Acute Phase-Initial 48 Hours | STARTED | Acute Phase: Sodium Zirconium Cyclosilicate (ZS) 1.25 g TID | 154 | |
| Acute Phase-Initial 48 Hours | STARTED | Acute Phase: ZS 2.5 g TID | 141 | |
| Acute Phase-Initial 48 Hours | STARTED | Acute Phase: ZS 5 g TID | 158 | |
| Acute Phase-Initial 48 Hours | STARTED | Acute Phase: ZS 10 TID | 143 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: Placebo Matched to ZS 1.25g QD | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: ZS 1.25 g QD | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: Placebo Matched to ZS 2.5 g QD | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: ZS 2.5 g QD | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: Placebo Matched to ZS 5 g QD | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: ZS 5 g QD | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: Placebo Matched to ZS 10 g QD | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: ZS 10 g QD | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: ZS 1.25 (Acute Phase: Placebo) | 0 | |
| Acute Phase-Initial 48 Hours | STARTED | Subacute Phase: ZS 2.5 g (Acute Phase: Placebo) | 0 | |
| Acute Phase-Initial 48 Hours | COMPLETED | Acute Phase: Placebo | 157 | |
| Acute Phase-Initial 48 Hours | COMPLETED | Acute Phase: Sodium Zirconium Cyclosilicate (ZS) 1.25 g TID | 150 | |
| Acute Phase-Initial 48 Hours | COMPLETED | Acute Phase: ZS 2.5 g TID | 137 | |
| Acute Phase-Initial 48 Hours | COMPLETED | Acute Phase: ZS 5 g TID | 152 | |
| Acute Phase-Initial 48 Hours | COMPLETED | Acute Phase: ZS 10 TID | 140 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01737697/flow